2023-06-02 06:16:00
Biospectator Reporter Seo Yoon-seok
Scheduled to be listed on the KOSDAQ in the middle of this month after public offering on the 5th and 7th
Qratis has confirmed the public offering price at 4,000 won.
Initially, Curatis’ hopeful offering price band was to raise 3.5 million shares at 6,500 to 8,000 won and raise 22.75 billion to 28 billion won. However, due to the lowering of the public offering price, the offering amount was reduced to 14 billion won.
Curatis announced on the 2nd that the public offering price was set at 4,000 won as a result of demand forecasting for institutional investors on the 30th and 31st of last month.
In this demand forecast, a total of 435 institutional investors participated in the recruitment of 2,625,000 shares, or 75% of the total public offering, recording a competition rate of 52.89 to 1.
Quratis plans to use the raised funds mainly for the phase 2b/3 clinical trials of ‘QTP101’, a tuberculosis vaccine candidate for adults and adolescents.
Curatis’ general public offering stock subscription will be held on the 5th and 7th for 875,000 stocks, or 25% of the total public offering stocks. The representative managers are Daishin Securities and Shinyoung Securities. Curatis is scheduled to be listed on the KOSDAQ market in the middle of this month.
Cho Kwan-gu, CEO of Curatis, said, “We will speed up the development with the goal of commercializing a tuberculosis vaccine for adults and adolescents in 2025 by promoting QTP101 clinical trials at a high speed.”
Established in 2016, Quratis is developing adult and adolescent tuberculosis vaccine QTP101 as its main pipeline. The only existing tuberculosis vaccine is BCG for infants, and it has a limitation that the vaccine effect disappears 10 to 15 years after vaccination. Curatis is developing a tuberculosis vaccine for adults and adolescents that boosts the body’s immune response formed with BCG, and last year received approval from the Ministry of Food and Drug Safety for a global integrated phase 2b/3 clinical trial plan (IND).
1685691541
#Quratis #public #offering #price #won #confirmed..The #public #offering #price #band